Rapid Detection and Identification of Bacterial Pathogens Using Novel Molecular Technologies: Infection Control and Beyond
Open Access
- 1 February 2007
- journal article
- review article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 44 (3) , 418-423
- https://doi.org/10.1086/510684
Abstract
In the movie Top Gun Tom Cruise's character, Pete Mitchell (otherwise known as “Maverick”), remarks “I feel the need ... the need for speed.” This is a sentiment felt by many infectious diseases clinicians and clinical microbiologists, particularly when confronted with a patient who is seriously ill, getting progressively worse, and for whom an infectious etiology has yet to be identified. The need for speed also is a factor when (1) a physician awaits the results of standardized antimicrobial susceptibility testing for an infectious agent that has been isolated from a patient whose condition is deteriorating clinically (despite receipt of empirical therapy) and (2) an infection control practitioner awaits the results of tests to determine whether a patient is colonized or infected with methicillin-resistant Staphylococcus aureus (MRSA) or vancomycin-resistant enterococci (VRE) and requires isolation. It is in these types of situations that molecular diagnostic methods can provide the data needed more rapidly and, in many cases, more cost effectively than traditional culture methods.Keywords
This publication has 17 references indexed in Scilit:
- Impact of rapid in situ hybridization testing on coagulase-negative staphylococci positive blood culturesJournal of Antimicrobial Chemotherapy, 2006
- Rapid Molecular Detection of Methicillin-Resistant Staphylococcus aureusJournal of Clinical Microbiology, 2006
- Cost savings with implementation of PNA FISH testing for identification of Candida albicans in blood culturesDiagnostic Microbiology and Infectious Disease, 2006
- Real-Time PCR in Clinical Microbiology: Applications for Routine Laboratory TestingClinical Microbiology Reviews, 2006
- Multicenter Evaluation of a Candida albicans Peptide Nucleic Acid Fluorescent In Situ Hybridization Probe for Characterization of Yeast Isolates from Blood CulturesJournal of Clinical Microbiology, 2005
- Direct Identification of Major Blood Culture Pathogens, Including Pseudomonas aeruginosa and Escherichia coli , by a Panel of Fluorescence In Situ Hybridization Assays Using Peptide Nucleic Acid ProbesJournal of Clinical Microbiology, 2005
- Detection of Methicillin-Resistant Staphylococcus aureus Directly from Nasal Swab Specimens by a Real-Time PCR AssayJournal of Clinical Microbiology, 2004
- Rapid Detection and Estimation by Pyrosequencing of 23S rRNA Genes with a Single Nucleotide Polymorphism Conferring Linezolid Resistance in EnterococciAntimicrobial Agents and Chemotherapy, 2003
- Direct Identification of Staphylococcus aureus from Positive Blood Culture BottlesJournal of Clinical Microbiology, 2003
- Monitoring Resistance to Human Immunodeficiency Virus Type 1 Protease Inhibitors by PyrosequencingJournal of Clinical Microbiology, 2001